Trials / Completed
CompletedNCT04219098
Pain After Preoperative UltraSound Guided Hip Injections for Total Hip Arthroplasty (PUSH)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Anne Arundel Health System Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the accuracy of Butterfly IQ ultrasound for intra-articular hip injections, and to see if an injection given intra-articular before incision provides any benefit in preemptive pain relief or blood loss reduction.
Detailed description
This study is designed to be prospective randomized (1:1) controlled independent trial. Subjects are male and female, aged 18 and above, who are suitable candidates for either a unilateral (i.e. single) total hip replacement. Subjects that are scheduled with a single, extensively trained Physician Assistant assisting in their surgery will be exclusively included. This is single site study with projected enrollment of 150 subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Butterfly IQ | 10ml of solution with .5cc (or one drop) sterile methylene blue will be injected intra-articularly under ultrasound guidance after a sterile prep. The remaining 20ml will be injected into the periarticular tissues after prosthesis implantation before closure. |
| OTHER | Standard of Care | The entire volume will be injected into the periarticular tissues after prosthesis implantation before closure. |
Timeline
- Start date
- 2020-02-01
- Primary completion
- 2021-07-30
- Completion
- 2021-08-30
- First posted
- 2020-01-06
- Last updated
- 2024-08-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04219098. Inclusion in this directory is not an endorsement.